找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinician’s Manual: Treatment of Hypertension; Third Edition Franz H Messerli Book 2011Latest edition Springer Healthcare Ltd. 2011 Clinica

[復制鏈接]
樓主: intern
31#
發(fā)表于 2025-3-26 21:02:14 | 只看該作者
32#
發(fā)表于 2025-3-27 04:45:49 | 只看該作者
ce..Includes dozens of clear and informative tables and figures to maximize comprehension..Addresses the most recent?and crucial developments in a very common chronic condition..Gives a comprehensive review of currently available medications and combination therapy..Approximately one billion people
33#
發(fā)表于 2025-3-27 08:26:19 | 只看該作者
Conclusion: The Miscellarian Race, same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garage, mother-in-law visiting) seem good enough to rationalize that day’s high BP as an exception and delay further therapeutic intervention.
34#
發(fā)表于 2025-3-27 12:52:28 | 只看該作者
35#
發(fā)表于 2025-3-27 16:27:04 | 只看該作者
36#
發(fā)表于 2025-3-27 19:49:54 | 只看該作者
Fashions and fads,ngual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP in a completely uncontrolled way, and such an abrupt BP drop has been associated with acute MI, stroke and death. Clearly, this is BP cosmetics and should be considered malpractice.
37#
發(fā)表于 2025-3-27 22:32:13 | 只看該作者
38#
發(fā)表于 2025-3-28 05:29:45 | 只看該作者
Evidence-based versus eminence-based therapy,that out of 100 screened patients with isolated systolic hypertension only one was included in the SHEP study and 99 were excluded for one reason or another. Can the evidence derived from 1% of the population be extrapolated to the remaining 99%?
39#
發(fā)表于 2025-3-28 10:14:13 | 只看該作者
https://doi.org/10.1007/978-1-907673-32-0Clinical; Professional; Reference; Cardiology
40#
發(fā)表于 2025-3-28 13:15:21 | 只看該作者
978-1-907673-08-5Springer Healthcare Ltd. 2011
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 10:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
沙田区| 应城市| 玉屏| 镇宁| 汾阳市| 贡山| 精河县| 光泽县| 隆回县| 昭苏县| 宁强县| 永仁县| 常德市| 姚安县| 鱼台县| 肃南| 西和县| 蒲城县| 康定县| 浦北县| 临西县| 成武县| 太康县| 方正县| 梁平县| 子长县| 炎陵县| 漯河市| 贺兰县| 石景山区| 扎赉特旗| 金坛市| 民勤县| 蓬溪县| 南丹县| 项城市| 洛南县| 资阳市| 开江县| 镇赉县| 北碚区|